The Oncology Institute, Inc. (NASDAQ: TOI) reported Q4 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $71.4 million versus the consensus estimate of $64.73 million.

GUIDANCE:

The Oncology Institute, Inc. sees FY2023 revenue of $290-320 million, versus the consensus of $309 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.